Mark B. Logan
Founder presso TearSolutions, Inc.
Profilo
Mark B.
Logan is the founder of TearSolutions, Inc. (founded in 2013) and holds the title of Director.
He is currently the Director at Public Policy Virginia, The UVA Heart & Vascular Center, and Trustee at Southern Environmental Law Center.
In the past, he served as Chairman, President & Chief Executive Officer at AMO Manufacturing USA LLC (1994-2001), Chairman & Chief Executive Officer at INSMED Pharmaceuticals, Inc. (1992-1994), Chief Operating Officer, Director & Executive VP at Bausch & Lomb, Inc., Independent Director at STAAR Surgical Co. (2011-2014), Independent Director at VIVUS, Inc. (1999-2014), Director at Abgenix, Inc. (1997-2006), and Group President at Becton, Dickinson & Co. (1980).
Mr. Logan obtained his undergraduate degree from Hiram College.
Posizioni attive di Mark B. Logan
| Società | Posizione | Inizio |
|---|---|---|
| Public Policy Virginia | Director/Board Member | - |
| Southern Environmental Law Center | Director/Board Member | 01/01/2002 |
| The UVA Heart & Vascular Center | Director/Board Member | - |
TearSolutions, Inc.
 TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Founder | 01/01/2014 |
Precedenti posizioni note di Mark B. Logan
| Società | Posizione | Fine |
|---|---|---|
| VIVUS, INC. | Chairman | - |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Director/Board Member | 01/01/2006 |
AMO Manufacturing USA LLC
 AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology AMO Manufacturing USA LLC engages in the design, develop and manufacture of excimer refractive surgical systems. It is designed to re-contour the front surface of the cornea of the human eye. The company was founded in 1988 and is headquartered in Santa Clara, CA. | Chairman | 01/05/2001 |
INSMED Pharmaceuticals, Inc.
 INSMED Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology INSMED Pharmaceuticals, Inc. develops products for the diagnosis and treatment of conditions associated with insulin resistance. The company is headquartered in Richmond, VA. | Chairman | 01/10/1994 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 31/12/1980 |
Formazione di Mark B. Logan
| Hiram College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| STAAR SURGICAL COMPANY | Health Technology |
| Aziende private | 9 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
AMO Manufacturing USA LLC
AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology AMO Manufacturing USA LLC engages in the design, develop and manufacture of excimer refractive surgical systems. It is designed to re-contour the front surface of the cornea of the human eye. The company was founded in 1988 and is headquartered in Santa Clara, CA. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
INSMED Pharmaceuticals, Inc.
INSMED Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology INSMED Pharmaceuticals, Inc. develops products for the diagnosis and treatment of conditions associated with insulin resistance. The company is headquartered in Richmond, VA. | Health Technology |
| Public Policy Virginia | |
| Southern Environmental Law Center | |
| The UVA Heart & Vascular Center | |
TearSolutions, Inc.
TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA. | Health Technology |
- Borsa valori
- Insiders
- Mark B. Logan
